Stock Events

Stock Events

Medincell. 

$34.39
32
+$27.41+392.98% Friday 20:44

Statistics

Day High
6.98
Day Low
6.98
52W High
34.39
52W Low
6.98
Volume
21,644
Avg. Volume
6
Mkt Cap
1.14B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16JunExpected
Q1 2023
Q3 2023
Q1 2024
Q3 2024
Q1 2025
Q3 2025
Next
-0.61
-0.4
-0.19
0.02
Expected EPS
0.02005491246
Actual EPS
N/A

Financials

-73.02%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
55.28MRevenue
-40.36MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MDCLF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Alnylam Pharmaceuticals specializes in RNAi therapeutics, competing in the drug delivery and development space similar to MedinCell's focus on controlled-release drug delivery technologies.
Ionis Pharmaceuticals
IONS
Mkt Cap12.03B
Ionis Pharmaceuticals, known for its RNA-targeted drug discovery and development, competes with MedinCell in the development of novel therapeutics.
Sarepta Therapeutics
SRPT
Mkt Cap2.51B
Sarepta Therapeutics, focusing on RNA-based therapeutics, particularly for rare diseases, competes in the innovative drug development sector alongside MedinCell.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals, with its focus on creating new treatments for serious diseases, shares the innovative drug development market with MedinCell.
Biogen
BIIB
Mkt Cap22.63B
Biogen, a biotechnology company specializing in therapies for neurological diseases, competes with MedinCell in the biopharmaceutical innovation and development space.
AMGEN
AMGN
Mkt Cap160.66B
Amgen, a biopharmaceutical company, competes in developing novel therapeutics, similar to MedinCell's focus on innovative drug delivery systems.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals, known for its innovative biopharmaceuticals, competes with MedinCell in the area of drug development and novel therapies.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences, focusing on antiviral drugs for infections like HIV, hepatitis B, hepatitis C, and influenza, competes in the pharmaceuticals and biotechnology industry alongside MedinCell.
Novo Nordisk
NVO
Mkt Cap217.54B
Novo Nordisk, a global healthcare company with a leading position in diabetes care, competes with MedinCell in the broader pharmaceuticals market, particularly in innovative drug delivery solutions.
Pfizer
PFE
Mkt Cap140.15B
Pfizer, a global pharmaceutical corporation, competes across various therapeutic areas, including those targeted by MedinCell, with its extensive research and development in novel pharmaceuticals.

About

MedinCell S.A., a pharmaceutical company, develops long acting injectables in various therapeutic areas in France. It develops solutions based on BEPO, a long-acting injectable technology; and offers UZEDY (mdc-IRM) for the treatment of schizophrenia in adults. The company's products in development include mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain and inflammation; and mdc-TJK, a subcutaneous injection that is in Phase III clinical trials for use in the treatment of schizophrenia. Its product candidates in preclinical trials include mdc-WWM for contraception; and mdc-STM for malaria. MedinCell S.A. was incorporated in 2003 and is headquartered in Jacou, France.
Show more...
CEO
Mr. Christophe Douat
Employees
131
Country
FR
ISIN
FR0004065605

Listings

F
DE
MEB.F
PA
FR
MEDCL.PA
OTC Link
US
MDCLF
LSE
GB
0ACH.LSE

0 Comments

Share your thoughts

FAQ

What is Medincell. stock price today?▼
The current price of MDCLF is $34.39 USD — it has increased by +392.98% in the past 24 hours. Watch Medincell. stock price performance more closely on the chart.
What is Medincell. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Medincell. stocks are traded under the ticker MDCLF.
What is Medincell. market cap?▼
Today Medincell. has the market capitalization of 1.14B
When is the next Medincell. earnings date?▼
Medincell. is going to release the next earnings report on June 16, 2026.
What were Medincell. earnings last quarter?▼
MDCLF earnings for the last quarter are -0.57 USD per share, whereas the estimation was -0.31 USD resulting in a -88.46% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Medincell. revenue for the last year?▼
Medincell. revenue for the last year amounts to 55.28M USD.
What is Medincell. net income for the last year?▼
MDCLF net income for the last year is -40.36M USD.
How many employees does Medincell. have?▼
As of April 05, 2026, the company has 131 employees.
In which sector is Medincell. located?▼
Medincell. operates in the Health Care sector.
When did Medincell. complete a stock split?▼
Medincell. has not had any recent stock splits.
Where is Medincell. headquartered?▼
Medincell. is headquartered in Jacou, FR.